13F HOLDINGS REPORT
OUP Management Co., LLC
Quarter ended Q2 2023 · Filed April 24, 2023 · Accession 0000950123-23-003359
Total Value
$50.1M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Aerovate Therapeutics Inc. | 008064107 | 603,762 | $12.2M | 24.30% |
| 2 | Centessa Pharmaceuticals plc | CNTA | 2,937,615 | $11.3M | 22.57% |
| 3 | DICE Therapeutics Inc. | 23345J104 | 268,346 | $7.7M | 15.34% |
| 4 | PMV Pharmaceuticals, Inc. | PMVP | 989,232 | $4.7M | 9.42% |
| 5 | Cyteir Therapeutics, Inc. | 23284P103 | 2,459,572 | $4.5M | 8.93% |
| 6 | ionQ, Inc. | IONQ-WT | 389,668 | $2.4M | 4.78% |
| 7 | Vor Biopharma Inc. | VOR | 374,714 | $2.0M | 4.02% |
| 8 | Prime Medicine, Inc. | PRME | 121,255 | $1.5M | 2.98% |
| 9 | Selecta Biosciences, Inc. | 816212104 | 862,543 | $1.2M | 2.39% |
| 10 | Graphite Bio | 38870X104 | 406,308 | $995,455 | 1.99% |
| 11 | Precision BioSciences, Inc. | DTIL | 1,123,913 | $846,981 | 1.69% |
| 12 | eFFECTOR Therapeutics, Inc. | 28202V108 | 1,025,697 | $361,763 | 0.72% |
| 13 | Spero Therapeutics, Inc. | SPRO | 249,070 | $361,152 | 0.72% |
| 14 | Homology Medicines, Inc. | 438083107 | 64,000 | $65,920 | 0.13% |